Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Rodin Therapeutics Appoints CEO

This article was originally published in Scrip

Executive Summary

Rodin Therapeutics has appointed Adam J. Rosenberg CEO and a member of its board. Rosenberg is the co-founder of various companies including Clean Membranes, where he was also on the board; Faber Law Group; and most recently, Teleos Therapeutics for which he was also director and CEO. He has also served in interim executive roles with various healthcare and biotech companies including Brightstar (acquired by SoftBank), and served on the advisory board of Gecko Health Innovations (acquired by Teva Pharmaceuticals).



Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst